INSIGHT 2 : a Phase II study of tepotinib plus osimertinib in MET-amplified NSCLC and first-line osimertinib resistance
Source
Future oncology - ISSN 1479-6694- () p.
Differentiating benign and malignant solitary pulmonary nodules through exhaled breath analysis
Source
ERJ Open Research - ISSN 2312-0541-12:1 (2026) p. 1-12
Multi-omic screening for pleural mesothelioma in Asbestos-Exposed Populations : a literature review and Recommendations
Source
Lung cancer: journal of the International Association for the ¶¶Òõ¶ÌÊÓƵ of Lung Cancer - ISSN 0169-5002-212 (2026) p. 1-12
Optimizing COPD care in Belgium : a multidisciplinary expert consensus on cardiopulmonary risk management
Source
International journal of chronic obstructive pulmonary disease - ISSN 1178-2005-21 (2026) p. 1-20
Methylation biomarkers can distinguish pleural mesothelioma from healthy pleura and other pleural pathologies
Source
Molecular Oncology - ISSN 1574-7891-20:4 (2026) p. 933-946